J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment… EP News Bureau Jan 10, 2024 ADCs continue to be the hot topic in big pharma. Prior to the announced J&J deal, last year alone saw 155 deals struck for the…
